How to improve recognition and diagnosis of depressive syndromes using international diagnostic criteria.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  The British journal of general practice : the journal of the Royal College of General Practitioners

• Publication date

  1998-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 9692284PMCID PMC1410164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of recurrent brief depression in primary care

  2005cited by this paper
• Recognition and management of depression in general practice: consensus statement.

  1992cited by this paper
• Telematics: a new tool for epidemiological surveillance of diarrhoeal diseases in the Aquitaine sentinel network.

  1990cited by this paper
• Anxiety and depression in a primary care clinic. Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments.

  1987cited by this paper

• Detecting major depressive disorder presence using passively-collected wearable movement data in a nationally-representative sample.

  2023cites this paper
• Validation of the Traditional Chinese Version of the Pittsburgh Fatigability Scale for Older Adults

  2021cites this paper
• Fatigue, sleep and depression: An exploratory interRAI study of older adults.

  2020cites this paper
• Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments

  2019cites this paper
• An Internet-based survey of the dance fitness program OULA

  2018cites this paper
• Fatigue and Major Depressive Disorder - A Systematic Review of Etiology, Maintenance, Diagnosis and Treatment

  2016cites this paper
• The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans.

  2016cites this paper
• Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trials

  2015cites this paper
• Qualitative Research on Fatigue Associated with Depression: Content Validity of the Fatigue Associated with Depression Questionnaire (FAsD-V2)

  2015cites this paper
• What can inactivity (in its various forms) reveal about affective states in non-human animals? A review

  2015cites this paper
• Understanding Mental and Physical Fatigue Complaints in Those With Depression and Insomnia

  2014cites this paper
• Resolution of sleepiness and fatigue: A comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union

  2014influential citation
• Early Career Psychiatrists Meta-Analysis

  2013cites this paper
• Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.

  2013cites this paper
• Beyond symptoms: defining primary care mental health clinical assessment priorities, content and process.

  2012cites this paper
• The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition

  2012cites this paper
• Development and validation of a patient-report measure of fatigue associated with depression.

  2011cites this paper
• Fatigue in female patients with major depression: the effect of comorbid anxiety disorders.

  2011cites this paper
• Psychometric evaluation of the Fatigue Severity Scale in patients with major depression

  2011cites this paper
• Depression, Fatigue, and Pre-Sleep Arousal: A Mediation Model

  2010cites this paper
• The Fatigue Questionnaire: Standardization in patients with major depression.

  2010cites this paper
• Sleep disturbances in relation to fatigue in major depression.

  2009cites this paper
• Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants

  2009cites this paper
• Fatigue and somatic anxiety in patients with major depression.

  2009cites this paper
• Core symptoms of major depressive disorder: relevance to diagnosis and treatment

  2008cites this paper
• Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial.

  2008cites this paper
• Fatigue in Parkinson's disease: A review

  2007cites this paper
• Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.

  2007cites this paper
• The other face of depression, reduced positive affect: the role of catecholamines in causation and cure

  2007cites this paper
• Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion

  2007cites this paper
• Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment.

  2006cites this paper
• Symptoms of fatigue and sleepiness in major depressive disorder.

  2006cites this paper
• Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.

  2006cites this paper
• Modafinil Augmentation of SSRI Therapy in Patients with Major Depressive Disorder and Excessive Sleepiness and Fatigue: A 12-Week, Open-label, Extension Study

  2006cites this paper
• The many faces of fatigue in major depressive disorder.

  2005influential citation
• A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.

  2005cites this paper
• Mood, energy, cognition, and physical complaints: a mind/body approach to symptom management during the climacteric.

  2005cites this paper
• A Prospective Trial of Modafinil as an Adjunctive Treatment of Major Depression

  2004cites this paper
• Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue.

  2004cites this paper
• Épisode dépressif majeur : dix ans d’expérience thérapeutique avec la fluoxétine

  2004cites this paper
• [Fluoxetine: an update of its use in major depressive disorder in adults].

  2004cites this paper
• Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.

  2003cites this paper
• Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder.

  2003cites this paper
• Detection of Substance Use Disorders in Patients Presenting with Depression

  2002cites this paper
• Improved ability to identify symptoms of major depressive disorder (MDD) in general practice

  2001cites this paper
• Changes in energy during treatment of depression: an analysis of fluoxetine in double-blind, placebo-controlled trials.

  2000cites this paper
• Increased occurrence of depression in psychosis-prone subjects: a follow-up study in primary care settings.

  1999cites this paper
• cogni-Adjunctive Modafinil at Initiation of Treatment With a Selective Serotonin Reuptake Inhibitor Enhances the Degree and Onset of Therapeutic Effects in Patients With Major Depressive Disorder and Fatigue

  year unknowncites this paper
• Eρευνητική εργασία Fatigue and somatic anxiety in patients with major depression

  year unknowncites this paper